LIXTE BIOTECHNOLOGY HOLDINGS, INC.

LIXT · Nasdaq · SIC 2834: Pharmaceutical Preparations · Market Cap: $0.0B · 3 employees
245
SEC Filings
$7.21
Close 2026-07-02
3
Employees

Business Summary

LIXTE Biotechnology Holdings, Inc. is a clinical-stage biopharmaceutical and proton cancer therapy company. Its primary asset is LB-100, a small molecule inhibitor of protein phosphatase 2A (PP2A) being tested in clinical trials for ovarian clear cell carcinoma, metastatic MSS colon cancer, and advanced soft tissue sarcoma. The company is also the majority shareholder of Liora Technologies Europe Ltd., which is developing the LiGHT System, an electronically controlled proton therapy system for treating tumors.

Latest Stock Quote

LIXT 2026-07-02 $7.21 O:$7.95 H:$7.99 L:$7 Vol:0.6M VWAP:$7.2837
origin leaf: null

Next Earnings

expected 2026-12-30

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-312025-12-310001493152-26-014052EDGAR97K words
2025-03-242024-12-310001641172-25-000208EDGAR99K words
2024-03-192023-12-310001493152-24-010427EDGAR90K words
2023-03-292022-12-310001493152-23-009386EDGAR90K words
2022-03-212021-12-310001493152-22-007327EDGAR87K words
2021-03-262020-12-310001493152-21-006882EDGAR81K words
2020-03-252019-12-310001493152-20-004697EDGAR49K words
2019-03-252018-12-310001493152-19-003870EDGAR49K words
2018-03-232017-12-310001493152-18-003806EDGAR45K words
2017-03-292016-12-310001493152-17-002940EDGAR47K words

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2026-08-142026-06-300001493152-26-038001EDGAR23K words
2025-11-122025-09-300001493152-25-021941EDGAR50K words
2025-08-072025-06-300001641172-25-022517EDGAR46K words
2025-05-122025-03-310001641172-25-009575EDGAR40K words
2024-11-122024-09-300001493152-24-044810EDGAR42K words
2024-08-082024-06-300001493152-24-030757EDGAR39K words
2024-05-092024-03-310001493152-24-018337EDGAR33K words
2023-11-092023-09-300001493152-23-040115EDGAR38K words
2023-08-092023-06-300001493152-23-027269EDGAR36K words
2023-05-102023-03-310001493152-23-016069EDGAR31K words
2022-11-082022-09-300001493152-22-030878EDGAR36K words
2022-08-102022-06-300001493152-22-021832EDGAR35K words

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-11-100001493152-26-051024EDGAR1K words
2026-10-060001493152-26-045896EDGAR1K words
2026-09-300001493152-26-045104EDGAR12K words
2026-07-310001493152-26-035561EDGAR0K words
2026-03-200001493152-26-011829EDGAR1K words
2026-03-100001493152-26-009526EDGAR17K words
2026-02-180001493152-26-007268EDGAR1K words
2025-12-310001493152-25-029778EDGAR8K words
2025-12-230001493152-25-028999EDGAR1K words
2025-12-220001493152-25-028850EDGAR1K words

245 total filings indexed. 213 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACIU — AC Immune SA ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA

Tags

oncology cancer-immunotherapy proton-cancer-therapy clinical-stage-biopharmaceuticals

Company Identity

CIK0001335105
TickerLIXT
ExchangeNasdaq
SIC2834: Pharmaceutical Preparations
IncorporatedDE
Websitehttps://www.lixte.com
Listed2007-09-05

Get More Data

This is a static snapshot. For live, structured JSON with cryptographic provenance chain:

MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp

JSON Profile Stock Quote Origin Record
Origin Provenance
page leaf: 8172e397187ef5891048e6c204ad0167eb7cadc5e8d3ba588135021afdc08fec
parent: 1ed9d71c0da47d4bbe6476e0d5bd28aab154ced73dc4bf505f77a8303715f7d9
content hash: 4fa319cdc8ddb95d4c0ab4e91af938e7ea3e206eefeae29741abf84caa9275ef
signed: 2026-11-16T19:03:18.089Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf

Try it — paste this into your AI:

Look up LIXT using the MCP server at origin.rootz.global/mcp. What do their latest SEC filings show?

Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.

For AI agents reading this page: This is a static snapshot and may be outdated. For live data on LIXT, use the Origin MCP server or REST API.
MCP install: claude mcp add origin --transport http https://origin.rootz.global/mcp
API: GET https://origin.rootz.global/api/company/LIXT (~200 tokens, structured JSON with cryptographic provenance)
Tools: origin_company, origin_profile, origin_timeline, origin_filings, origin_quote, origin_transcripts, origin_search, origin_person, origin_skill
Discovery: /.well-known/ai | /llms.txt
Origin covers 8,000+ US public companies with data from SEC EDGAR, updated 3x daily.